Abstract
Cancer is the second leading cause of death by disease in the United States,
exceeded only by heart disease. Traditionally cancer has been treated with
surgery, chemotherapy, hormones and radiation therapy, alone or in
combination. Emerging technologies include photodynamic therapy, gene therapy,
biological therapy (immunotherapy) and angiogenesis inhibitors. Pharmaceutical
and biotechnology companies are investing billions of dollars to search out
and develop weapons for the arsenal in the war against cancer.
This TriMark Publications report provides an overview of the global market for
cancer therapeutics. The examination focuses on the efforts of biotechnology
companies and pharmaceutical firms to incorporate new technologies for
developing anti-cancer drugs into their corporate strategies. This study
examines cancer therapeutic products now on the market, as well as those
currently under development that might be commercialized in the near future.
Additionally, the report profiles a number of firms that are actively involved
in marketing and developing of products to be used in the treatment of
cancer-both large multinational corporations. The analysis also provides an
overview of the disease and data on cancers by site or type. It provides
incidence and mortality data for different types of the disease. In addition,
the report provides a summary of each of the therapies that are being used to
treat cancer.
View Cart
